Highbridge Capital Management’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-9,800
Closed -$391K 1953
2017
Q4
$391K Buy
+9,800
New +$408K 0.01% 1064
2016
Q4
Sell
-200,000
Closed -$10.7M 1765
2016
Q3
$10.7M Buy
+200,000
New +$9.28M 0.17% 143
2016
Q2
Sell
-50,400
Closed -$2.54M 1940
2016
Q1
$2.54M Buy
+50,400
New +$2.42M 0.04% 448
2015
Q4
Sell
-3,200
Closed -$210K 1975
2015
Q3
$210K Buy
+3,200
New +$212K ﹤0.01% 1364
2014
Q4
Sell
-83,100
Closed -$2.39M 1549
2014
Q3
$2.39M Buy
83,100
+33,300
+67% +$904K 0.03% 447
2014
Q2
$1.3M Buy
+49,800
New +$1.29M 0.02% 505

Other funds holding IMPV

Highbridge Capital Management's IMPV Position: Q3 2018 in Review

Highbridge Capital Management sold out of Imperva, Inc. (IMPV) in Q3 2018, closing a stake of 102,861 shares — an estimated $4.96M sold.

Highbridge Capital Management first reported a position in IMPV in Q3 2013 and held it in 10 quarters. The position peaked at $8.73M in Q3 2016. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.

  • Highbridge Capital Management reported no remaining Imperva, Inc. position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 102,861 Imperva, Inc. shares in Q3 2018, an estimated $4.96M.
  • Highbridge Capital Management first reported a position in Imperva, Inc. in Q3 2013 and held it in 10 quarters.
  • Highbridge Capital Management's Imperva, Inc. position peaked at $8.73M in Q3 2016.
  • 168 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.